Atezolizumab in Advanced Hepatocellular Carcinoma: Good Things Come to Those Who Wait

Authors:

Abstract
Advanced hepatocellular carcinoma (HCC) patients present poor prognosis. However, recent years have seen the advent of several novel treatments in this setting, where the role of immune checkpoint ...

This publication has 47 references indexed in Scilit: